venBio Partners’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.03M | Hold |
|
|||||
|
2025
Q1 | $6.04M | Hold |
|
|||||
|
2024
Q4 | $16.2M | Hold |
|
|||||
|
2024
Q3 | $17.7M | Hold |
|
|||||
|
2024
Q2 | $58.5M | Hold |
|
|||||
|
2024
Q1 | $108M | Hold |
|
|||||
|
2023
Q4 | $144M | Hold |
|
|||||
|
2023
Q3 | $46.6M | Hold |
|
|||||
|
2023
Q2 | $72.8M | Hold |
|
|||||
|
2023
Q1 | $43.8M | Hold |
|
|||||
|
2022
Q4 | $109M | Hold |
|
|||||
|
2022
Q3 | $92.8M | Hold |
|
|||||
|
2022
Q2 | $78.5M | Hold |
|
|||||
|
2022
Q1 | $164M | Hold |
|
|||||
|
2021
Q4 | $208M | Hold |
|
|||||
|
2021
Q3 | $716M | Hold |
|
|||||
|
2021
Q2 | $530M | Hold |
|
|||||
|
2021
Q1 | $715M | Hold |
|
|||||
|
2020
Q4 | $836M | Hold |
|
|||||
|
2020
Q3 | $366M | Buy |
|